| [1] | Bartels U., Onar-Thomas A., Patel S.K., et al. (2022). Phase II trial of response-based radiation therapy for patients with localized germinoma: A Children's Oncology Group study. Neuro. Oncol. 24:974−983. DOI:10.1093/neuonc/noab270 |
| [2] | Frappaz D., Dhall G., Murray M.J., et al. (2022). EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults. Neuro. Oncol. 24:516−527. DOI:10.1093/neuonc/noab252 |
| [3] | Calaminus G., Frappaz D., Kortmann R.D., et al. (2017). Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial. Neuro. Oncol. 19:1661−1672. DOI:10.1093/neuonc/nox122 |
| [4] | Fangusaro J., Wu S., MacDonald S., et al. (2019). Phase II trial of response-based radiation therapy for patients with localized CNS nongerminomatous germ cell tumors: A Children's Oncology Group study. J. Clin. Oncol. 37:3283−3290. DOI:10.1200/JCO.19.00701 |
| [5] | Chao Z., Xiang H., Yijin G., et al. (2025). CACA guidelines for holistic integrative management of central nervous system germ cell tumor. Holist. Integ. Oncol. 40:1−21. DOI:10.1007/s44178-025-00168-2 |
| Chen Z., Cheng B.-x., Tang C.-p., et al. (2026). Practical guideline for the diagnosis and management of central nervous system germ cell tumors. The Innovation Oncology 1:100021. https://doi.org/10.59717/j.xinn-oncol.2026.100021 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Management of CNS GCTs.